U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07154212) titled 'Hepatitis B Virus Reactivation in COVID-19' on Sept. 02.
Brief Summary: The aim of this observational cohort study was to evaluate adherence to hepatitis B virus (HBV) screening guidelines in a country characterized by low HBV prevalence and assess the potential reactivation and progression of HBV infection in anti-HBV core antigen antibodies (anti-HBc) positive patients receiving corticosteroids for coronavirus disease 2019 (COVID-19).
Study Start Date: Nov. 01, 2020
Study Type: OBSERVATIONAL
Condition:
COVID-19 Pneumonia
Hypoxemia
Hepatitis B
Intervention:
DIAGNOSTIC_TEST: Hepatitis B virus infection
anti-hepatitis B virus ...